Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001248793 | SCV000821350 | pathogenic | Catecholaminergic polymorphic ventricular tachycardia 1 | 2023-10-03 | criteria provided, single submitter | clinical testing | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 115 of the RYR2 protein (p.Tyr115Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with RYR2-related disease (Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 572162). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RYR2 protein function. For these reasons, this variant has been classified as Pathogenic. |
Center For Human Genetics And Laboratory Diagnostics, |
RCV001248793 | SCV001422305 | likely pathogenic | Catecholaminergic polymorphic ventricular tachycardia 1 | 2019-12-10 | criteria provided, single submitter | clinical testing |